Rampudda, Mariaelisa
Ospedale P. Pederzoli – Casa di Cura Privata S.p.a.
3 papers on CoChat
Most cited papers
- Verified
Baricitinib restrains the immune dysregulation in patients with severe COVID-19
Bronte, V., Ugel, S., Tinazzi, E., Vella, A., De Sanctis, F., Canè, S., Batani, V., Trovato, R., Fiore, A., Petrova, V., et al. (2020) · Journal of Clinical Investigation
COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research
Cited by 281
- Verified
Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study.
Ruffatti, A., Del Ross, T., Ciprian, M., Bertero, M. T., Salvatore, S., Scarpato, S., Montecucco, C., Rossi, S., Caramaschi, P., Biasi, D., et al. (2011) · Annals of the Rheumatic Diseases
Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis Mechanisms
Cited by 184
- Verified
Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study
Ruffatti, A., Ross, T. D., Ciprian, M., Nuzzo, M., Rampudda, M., Bertero, M. T., Bergia, R., Caramaschi, P., Biasi, D., Capsoni, F., et al. (2009) · Annals of the Rheumatic Diseases
Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis Mechanisms
Cited by 106
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free